MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2023-24)
- Udyam number
- UDYAM-TS-20-0011896
RCC Laboratories India Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹68.9 Cr
▲ 31% YoY
Net profit · FY 2025
₹26.56 Cr
Net margin 38.6%
EBITDA · FY 2025
₹40.4 Cr
EBITDA margin 58.6%
Authorised capital
₹26.1 Cr
Registered with MCA
Paid-up capital
₹5.06 Cr
Issued & subscribed
Open charges
₹15.54 Cr
Satisfied ₹1.5 Cr
Company age
21 yrs
Est. 2005
Employees · EPFO
104
Provident fund records
About RCC Laboratories India Private Limited
Data last updated:
RCC Laboratories India Private Limited is a private limited company based in Hyderabad, Telangana, India, a subsidiary of Conress Labs (India) Private Limited. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 21 November 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2005PTC048111. Its GSTIN is 36AADCR1813J1ZH (Telangana). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹26.1 Cr and a paid-up capital of ₹5.06 Cr. It is led by directors including Ullmann Ludwig Gustav and Sai Prasad Devarajulu.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Genome Vally Turkapallyshameerpet Mandal Hyd 500078, Hyderabad, Telangana, India – 500078.
As per the financials filed for FY 2025, the company reported a revenue of ₹68.9 Cr, a growth of 31% compared to the previous year. For the same year it recorded a net profit of ₹26.56 Cr (net margin 38.6%) and EBITDA of ₹40.4 Cr (EBITDA margin 58.6%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 17% over five years.
The company has about 104 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
As per MCA filings, the company has open charges of ₹15.54 Cr and satisfied charges of ₹1.5 Cr on record.
RCC Laboratories India Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0011896). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website rcclabs.com.
Company details
CIN U24239TG2005PTC048111
Registration Number 048111
Incorporation Date 21 November 2005
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2024
Parent Company Conress Labs (India) Private Limited
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-TS-20-0011896
CIN history
RCC Laboratories India has one previous CIN (Corporate Identification Number): U24239AP2005PTC048111. The current CIN is U24239TG2005PTC048111, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TG2005PTC048111 | Current |
| U24239AP2005PTC048111 | Previous |
Recognitions & Rankings of RCC Laboratories India
Contact details
RCC Laboratories India Private Limited's registered office is in Hyderabad, Telangana. Its website is rcclabs.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressGenome Vally Turkapallyshameerpet Mandal Hyd 500078, Hyderabad, Telangana, India – 500078
- IndustryPharma, Pharma Contract R&D
To see the full contact details of RCC Laboratories India Private Limited, buy the company report.
Comprehensive company report
RCC Laboratories India Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of RCC Laboratories India is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of RCC Laboratories India Private Limited, buy the company report.
Financials of RCC Laboratories India Private Limited
FY 2024 filings availableRCC Laboratories India Private Limited reported revenue of ₹68.9 Cr (up 31% YoY) for FY 2025.
Revenue · FY 2025
₹68.9 Cr ▲ 31%
Net profit · FY 2025
₹26.56 Cr margin 38.6%
EBITDA · FY 2025
₹40.4 Cr margin 58.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 31%
3 years · compounded
▲ 3%
5 years · compounded
▲ 17%
EBITDA CAGR growth
1 year
▲ 54%
3 years · compounded
▼ 3%
5 years · compounded
▲ 24%
Revenue has grown at a compounded annual rate (CAGR) of 17% over five years, including 31% growth in the latest year. EBITDA rose 54% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹40.4 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹26.56 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 58.6% | ||||
| Net Profit Margin | 38.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of RCC Laboratories India Private Limited, buy the company report.
Board of directors of RCC Laboratories India Private Limited
RCC Laboratories India has 3 current directors and 12 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ullmann Ludwig Gustav | Director | 02 Dec 2009 | 16 Years 10 Months | Current |
| Sai Prasad Devarajulu Also directs: Bharat Biotech International Limited, RCC Nutra Fill Private Limited, Skebio Infra LLP and 4 more | Director | 20 Oct 2009 | 17 Years 0 Months | Current |
| Suchitra Ella Also directs: Bharat Biotech International Limited, RCC Nutra Fill Private Limited, Ellacrity Infratech Private Limited and 2 more | Director | 12 Jun 2020 | 6 Years 4 Months | Current |
Peer comparison
RCC Laboratories India Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ecron Acunova Limited | ₹75.29 Cr (FY 2025) | 20.0% | Bangalore, Karnataka, India | |||
| Sun Pharma Advanced Research Company Limited | ₹73.56 Cr (FY 2025) | -30.0% | Manjusar, Gujarat, India | |||
| RCC Laboratories India Private Limitedthis company | ₹68.9 Cr (FY 2025) | ₹26.56 Cr | 38.6% | 31.0% | 104 | Hyderabad, Telangana, India |
| Fortrea Clinical Development Private Limited | ₹64.26 Cr (FY 2025) | -8.0% | Bangalore, Karnataka, India | |||
| Lyrus Life Sciences Private Limited | ₹60.95 Cr (FY 2025) | -22.0% | Bangalore, Karnataka, India |
To see the full peer comparison of RCC Laboratories India Private Limited, buy the company report.
Auditor
RCC Laboratories India Private Limited is audited by P Murali & Co for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| P Murali & Co | FY 2023 | 007257S |
Shareholding
The shareholding of RCC Laboratories India Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of RCC Laboratories India Private Limited, buy the company report.
Charges & borrowings
Open charges
₹15.54 Cr
Satisfied charges
₹1.5 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 10 Mar 2021 | 100471385 | Others | ₹15.54 Cr | Open | |
| 26 Mar 2012 | 10352721 | Citi Bank N.A. | ₹1.5 Cr | Satisfied |
To see the full charge records of RCC Laboratories India Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving RCC Laboratories India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
RCC Laboratories India Private Limited has 4 MSME Form 1 returns on record between 2019 and 2020, listing 22 overdue payments to 8 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 8)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Sub Zero Labs Instruments | |||
| Unique Control System | |||
| Lakshmi Venkateshwara Enterprises | |||
| an individual supplier |
To see the full MSME payment records of RCC Laboratories India Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
RCC Laboratories India has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
1
Subsidiary companies
Key subsidiaries
| Company Name | CIN | Shares held |
|---|---|---|
| RCC Nutra Fill Private Limited | U33309KA2018PTC109329 |
To see the full group structure of RCC Laboratories India Private Limited, buy the company report.
Employees & EPFO
RCC Laboratories India Private Limited has a workforce of 104 employees on its EPFO records as of Apr 08, 2024, across 1 active EPFO establishment.
Employee count
104
Active EPFO establishments
1
Employee growth
-0.95%
GST
RCC Laboratories India has 3 GST registrations: 1 active and 2 cancelled or inactive.
Total GSTINs
3
Active
1
Cancelled / inactive
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AADCR1813J1ZH | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of RCC Laboratories India Private Limited, buy the company report.
Recent activity
RCC Laboratories India Private Limited has 13 board changes on record since 2007: 3 appointments and 10 cessations. The latest: Nikita Chopra ceased to be Company Secretary on 12 Sep 2021.
AGM
Rcc Laboratories India Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Rcc Laboratories India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Ceased
Nikita Chopra ceased to be Company Secretary.
Charges
A charge with Others amounted to Rs. 15.54 Cr with Charge ID 100471385 was registered on 10 Mar 2021.
Ceased
Suchitra Ella ceased to be Additional Director.
Appointed
Suchitra Ella was appointed as Director.
Charges
A charge registered on 26 Mar 2012 via Charge ID 10352721 with Citi Bank N.A. was fully satisfied on 07 Jun 2013.
Charges
A charge with Citi Bank N.A. amounted to Rs. 1.50 Cr with Charge ID 10352721 was registered on 26 Mar 2012.
Ceased
Krishna Murthy Ella ceased to be Director.
Ceased
Sai Prasad Devarajulu ceased to be Additional Director.
Appointed
Ullmann Ludwig Gustav was appointed as Director.
Appointed
Sai Prasad Devarajulu was appointed as Director.
7 earlier events are in the company report.
News
Frequently asked questions
RCC Laboratories India is an active private limited company based in Hyderabad, Telangana, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 21 November 2005 (21+ years old) and is registered under CIN U24239TG2005PTC048111.
RCC Laboratories India has 3 current directors:
- Ullmann Ludwig Gustav - Director
- Sai Prasad Devarajulu - Director
- Suchitra Ella - Director
The latest financial statements of RCC Laboratories India on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of RCC Laboratories India is 36AADCR1813J1ZH, registered in Telangana. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of RCC Laboratories India is U24239TG2005PTC048111. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
RCC Laboratories India was incorporated on 21 November 2005, making it 21+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of RCC Laboratories India by revenue are Ecron Acunova Limited, Sun Pharma Advanced Research Company Limited, Fortrea Clinical Development Private Limited, Lyrus Life Sciences Private Limited, all in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development).
Nikita Chopra ceased to be Company Secretary on 12 Sep 2021. Suchitra Ella ceased to be Additional Director on 16 Sep 2020. Suchitra Ella was appointed as Director on 12 Jun 2020. RCC Laboratories India has 13 board changes on record in total.
Yes, RCC Laboratories India is registered as a medium enterprise under Udyam registration (number: UDYAM-TS-20-0011896).
RCC Laboratories India has 4 MSME Form 1 returns on record between 2019 and 2020, listing 22 overdue payments to 8 micro and small suppliers. The latest return was filed on 17 Dec 2020.
RCC Laboratories India can be reached through the website rcclabs.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of RCC Laboratories India is at Genome Vally Turkapallyshameerpet Mandal Hyd 500078, Hyderabad, Telangana, India – 500078.